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Purpose: Osteoarthritis (OA) is a degenerative disease characterized by
the degradation of articular cartilage. Human bone marrow mesen-
chymal stem cells (BM-MSCs) have been presented as candidate cells for
cartilage tissue engineering due to their ability to undergo chondrogenic
differentiation after extensive expansion in vitro and stimulation with
various biomaterials in three-dimensional systems. Hyaluronic acid (HA)
is one of the major components of the hyaline cartilage and plays a key
role in maintaining chondrocytes function. PEPM [poly-(2-ethyl-2-pyr-
rolidone) methacrylate]-HA are semi-interpenetrated (SIPN) networks,
where this biopolymer is integrated as a building block for new
biocompatible therapeutic materials. This study is aimed at analyzing the
chondrogenic potential of BM-MSCs derived from OA patients, cultured
in PEPMHA hydrogels under hypoxia and normoxia environments,
simulating the physiological oxygen tension in cartilaginous regionsĂversus ambient air, respectively, as well as under static and semi-
dynamic conditions.
Methods: Human bone marrow MSCs isolated from OA patients, were
cultured in PEPMHA hydrogels, under hypoxia (5% pO2) or normoxia
environments (21% pO2), under static or semi-dynamic conditions (70
rpm). MSCs- only and chondrocytes (OA and normal) were seeded as
control. After 96 hours, cells’ viability was assessed using the alamar blue
assay. Cell-constructs were thereafter cultured for 21 days in a chondro-
genic differentiation medium, supplemented with the transforming
growth factor-b3 (TGF-b3), dexamethasone and retinoic acid. Histological
examination was performed using hematoxylin-eosin, alcian blue-PAS,
toluidine blue and safranin-O stainings, as well as immunohistochem-
istry analysis of types I, II and X collagen. Cell differentiation was
monitored by real-time PCR (types I, II collagen, aggrecan, MMP13 and
RUNX2). Fig.1
Results: BM- MSCs viability was assessed using the alamar blue assay.
After 96h seeding in PEPMHA hydrogels, under different conditions, cells
metabolic activity was altered although maintaining their viability (Figure
1) and therefore cell culture was performed for a longer period of time to
predict the suitability of this cell-construct for a cartilage tissue engi-
neering approach. After 21 days in a chondrogenic differentiation medium,
cells secreted an extracellular matrix incorporating types I, II collagen and
proteoglycans. Cells in normoxia, both under static or semi-dynamic
conditions, resulted in a more potent differentiation although in some
cases, MSCs were further differentiated to a premature hypertrophic state,
seen by the expression of type X collagen. Cells cultured under hypoxia
have shown a different behaviour, enabling the formation of a more stable
tissue, in the absence of hypertrophy.
Conclusions: MSCs derived from OA patients’ present a limitation for in
vitro chondrogenesis studies due to the imminent induction of a ﬁbro-
cartilaginous tissue. Culture in PEPMHA hydrogels alone was not
sufﬁcient to reverse this differentiation although from our results one
could speculate that hypoxia may delay terminal differentiation of
MSCs.
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Purpose: Therapeutic treatments for articular cartilage repair are
limited and where they exist, such as Autologous Chondrocyte
Implantation (ACI), procedures result in variable outcomes. We
hypothesise that a major factor affecting the outcome of ACI and related
cell-based therapies is the source of cells used. We discovered that
cartilage derived stem cells from normal tissue have a high cellular
proliferative potential, maintain the chondrogenic phenotype in vitro
and demonstrate a restricted differentiation potential, such that they do
not express collagen type X. However, there is also a need to investigate
the biology of cartilage derived stem cells from osteoarthritic (OA)
joints and determine their potential for use in autologous cartilage
repair treatments. This work describes the isolation and character-
isation of OA derived cartilage stem cells.
Methods: Normal and osteoarthritic human cartilage samples were
obtained with relevant ethical approval. Cartilage biopsies were enzy-
matically digested and subjected to differential adhesion to ﬁbronectin.
Colonies generated from a single cell were selected and expanded with
population doubling (PD) data collated at each passage. At PD30 and PD50,
the b galactosidase assay for senescence and the bromodeoxyuridine
incorporation assay (BrDU) for proliferative index were performed on
monolayer cell cultures. Normal and OA derived stem cell lines were
subjected to Single Telomere Length Analysis (STELA) to determine
average telomere length.
Results: The results demonstrate that differential adhesion to ﬁbronectin
allows generation of OA-derived stem cell lines. However, percentages of
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S273OA-derived stem cells in the cartilage cell mass were reduced compared to
normal tissue. OA-derived stem cell clones had highly variable life-spans
as measured by population doublings. When cultured long term, we
observed that some of the OA-derived stem cells lines expanded signiﬁ-
cantly more than others (>50PD) whilst remaining cell lines became
senescent at approximately 30PD. Quantitative assays for senescence and
proliferative index support the conclusion that the stem cell population in
OA cartilage is heterogeneous in nature. Average telomere length of OA
derived stem cell lines was more variable than normal stem cell lines
(Fig.1) and corresponded to their individual growth curves, where cell lines
with low average telomere length became senescent at approximately
30PD. The chondrogenic potency of OA-derived stem cell lines as assessed
by pellet culture was also variable.
Conclusions: These data demonstrate the presence of stem cells within
OA cartilage and, interestingly, describe the heterogeneity of life-span
within OA derived stem cell lines. This variability in stem cell charac-
teristics will have a major negative impact on clinical applications in
relation to stem cell potency and the capacity of cells to repair or
regenerate articular cartilage lesions. These ﬁndings have allowed us to
focus on developing methods of isolating highly proliferative stem cells
from OA cartilage. The future aim of which is to improve their potency
to that of normal stem cells in order that OA-derived stem cells will be
of beneﬁt in autologous tissue engineering procedures for cartilage
defects.542
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3Cryobiology Unit. CHUAC, A Coruña, SpainPurpose: Previous in vivo animal experiments are essential to develop
human clinical studies. The porcine joint size, weight-bearing require-
ments, and cartilage thickness more closely imitate the human condition
than other animal models. Human amniotic mesenchymal stromal cells
(hAMSC) and human amniotic epithelial cells (hAEC) are useful to repair
human joint cartilage in an in vitro human model. Previously to the
development of an in vivo porcine model for cartilage repair, it is necessary
to check the feasibility of the in vitro porcinemodel to prevent unnecessary
interventions in animals. We aimed to determine the most appropriated
type of human amniotic cell, the hAMSCs or the hAECs, to repair cartilage
in an in vitro porcine model.
Methods: HAM was used as support for the culture of hAMSCs or hAECs.
Focal injuries in swine joint cartilage biopsies were done. Afterwards,
a pellet of cells (hAMSCs or hAECs, depending on the repair model
developed) was implanted into the focal defects of cartilage. HAM, with
the cells grown on it, was placed in direct contact with the cartilage surface
to be repaired. These implants were cultured in chondrogenic medium, for
8 weeks. The repaired tissues were evaluated by histological analysis.
Results: hAMSCs and hAECs cultured on HAM were transplanted onto
focal injuries of porcine cartilage and, in some cases, they penetrated into
the nearby surface of the chondral defect (Fig. 1A and B). The Hematoxylin
and Eosin staining showed the viability of hAECs (Fig. 1C) and hAMSC (Fig.
1E) pellet inside of the chondral defect. There was integration between the
repaired tissue and native cartilage. However, the line between the
repaired and native cartilage was sharp (Fig. 1F). The morphology of the
repaired tissue with the hAECs, the morphology of the repaired tissue also
showed a ﬁbrocartilaginous appearance, however no repaired tissue was
observed in most of the experiments (Fig. 1D). Also, with these cells, the
new tissue had less cellularity. In the case of the hAMSC showed a ﬁbro-
cartilaginous appearance and a high cellularity (Fig. 1G and H). We per-
formed an ICRS macroscopic evaluation of cartilage repair (Table 1) to
compare both kinds of progenitor cells in the in vitro porcine model.
hAMSCs displayed better degree of defect repair, a little improved inte-
gration to border zone and, in general, higher overall repair assessment.
Conclusions: It was possible the use of human amniotic cells, the hAMSCs or
the hAECs, to develop an in vitro porcine model. However, hAMSCs showed
better results considering the ICRSmacroscopic evaluation of cartilage repair.
Therefore, hAMSCswould seem themost appropriated type of cells to develop
an in vivo porcinemodel. Support: Project funded by Servizo Galego de Saúde
(PS07/84), Catedra Bioiberica de la Universidade da Coruña and Instituto de
Salud Carlos III CIBER BBN CB06-01-0040. Emma Muiños has a grant from
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Figure 1. Histological analysis of hAECs (A-D) and hAMSCs (E-F) in vitro porcine
model.
Table 1: Mean assessment of hAECs and hAMSCs considering the ICRSmacroscopic
evaluation of cartilage repair.
